{"blog": [], "keywords": [{"value": "Mylan Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Perrigo Company", "name": "organizations", "rank": "2", "is_major": "Y"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/04/30/business/dealbook/mylan-again-raises-offer-for-perrigo.html", "document_type": "article", "byline": {"person": [{"middlename": "J.", "firstname": "Michael", "role": "reported", "rank": 1, "lastname": "de la MERCED", "organization": ""}], "original": "By MICHAEL J. de la MERCED"}, "type_of_material": "News", "multimedia": [{"url": "images/2015/04/30/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "legacy": {"wide": "images/2015/04/30/business/db-drug-web1/db-drug-web1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/04/30/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "legacy": {"xlarge": "images/2015/04/30/business/db-drug-web1/db-drug-web1-articleLarge.jpg", "xlargeheight": "372", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 372}, {"url": "images/2015/04/30/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/30/business/db-drug-web1/db-drug-web1-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "444", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Seeking to fend off an unwanted bid from Teva, Mylan increased its cash-and-stock offer for Perrigo.", "pub_date": "2015-04-30T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Mylan Raises Bid", "main": "Mylan Raises Offer for Perrigo Again and Is Rejected Again"}, "print_page": "5", "snippet": "Seeking to fend off an unwanted bid from Teva, Mylan increased its cash-and-stock offer for Perrigo.", "_id": "5540e32138f0d877377da3bd", "slideshow_credits": null, "abstract": "Mylan generic drug manufacturer raises its bid for Irish rival Perrigo, offer it says is valued at more than $34 billion; second attempt to acquire Perrigo is latest move in ongoing effort to fend off unwanted takeover bid by Teva Pharmaceuticals."}